Karla V. Ow Msn Fnp-Bc

Bridging Innovation in Multiple Myeloma Care: A Review of Novel Therapies

T-cell–based immunotherapies, such as chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies (bsAbs), have emerged as powerful treatment options for relapsed/refractory MM and will require investment in infrastructure, education, and interprofessional collaboration to ensure safe, equitable, and effec...